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Background and aims: Postoperative pain has always been considered by surgeons because of its various complications. The aim of this 
study was to compare the effect of intravenous, subcutaneous and suppository morphine in reducing post-hysterectomy pain.
Materials and Methods: In this clinical trial, 90 patients undergoing hysterectomy were randomized into three groups of 30 each using 
simple randomization, namely, intravenous, subcutaneous, and suppository morphine (10 mg). Before intervention and 4, 8, 12, and 16 
hours after intervention, pain intensity was measured using visual analogue scale (VAS). Relative frequency of nausea, vomiting, itching, 
bradypnea, and apnea in all groups was recorded. Data were analyzed by SPSS version16.0.
Results: Mean pain severity at 0 hour postoperatively (P=0.004), 4 hours postoperatively (P=0.009), 8 hours postoperatively (P=0.009), and 
12 hours postoperatively (P=0.001) was significantly higher in the suppository morphine group than in the other two groups. There was no 
significant difference in pain severity at 16 hours postoperatively among the three groups (P=0.446). According to the results of repeated 
measures ANOVA, changes in pain severity at the five intervals were statistically significant in all three groups (subcutaneous, intravenous, 
and suppository morphine groups) (P<0.001). There was also a statistically significant difference in pain severity at the studied intervals 
among the three groups (P<0.001). The frequency of nausea (P=0.05) and vomiting (P=0.84) was higher in the suppository group than in 
the other two groups, although the difference was not statistically significant (P=0.05).
Conclusion: The results of this study indicated better efficacy of subcutaneous and intravenous morphine in reducing post-hysterectomy 
pain compared with suppository morphine.
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Introduction 
Pain is considered as one of the vital signs that if neglected 
leads to many negative consequences (1). Pain is an 
important determinant of health-related quality of life 
that causes postoperative cardiovascular, gastrointestinal, 
psychological and pulmonary complications and disability 
and increases hospitalization and pain medication use 
(2-8). Treatment of acute pain and postoperative pain 
is important in health care settings. In recent years, 
many advances have been made in understanding the 
process of pain development and the development of 
pain relievers and pain relief techniques (9). Oral and 
intravenous administrations are methods of prescribing 
analgesic drugs for the control of postoperative 
acute pain. Oral administration of analgesic drugs 
is not suitable for controlling moderate to severe 
postoperative acute pain because it does not provide 
rapid and efficient pain relief (10,11). 
Hysterectomy is a common gynecological surgery that 
causes moderate to severe postoperative pain (12). Hence, 
the optimal management of post-hysterectomy pain 
is essential for preventing the development of chronic 
pain. Various treatments and analgesic administration 
routes can lead to various outcomes such as changes in 
visual analogue scale (VAS) scores, sedation, and even side 
effects (11,13). A study that compared the type of opioids 
used showed that oral administration was associated with 
delayed onset of analgesia and reduced patient satisfaction 
but needed shorter time to be accomplished. In contrast, 
intravenous morphine titration caused rapid and adequate 
pain relief (11). Considering that the opioid receptors are 
located at peripheral nerve terminals (14), the peripheral 
application of opioids is of clinical importance. In 
addition, the efficacy of intravenous, subcutaneous, and 
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suppository morphine in reducing postoperative pain 
has not been investigated. Therefore, we decided to 
compare subcutaneous, intravenous, and suppository 
administrations of morphine to compare their efficacy and 
complications.
Materials and Methods
In this triple-blind clinical trial, patients referred 
for hysterectomy to Hajar and Kashani Hospitals in 
Shahrekord in 2018 were enrolled. 
In this clinical trial, 90 patients undergoing hysterectomy 
were randomized into three groups of 30 each using simple 
randomization, namely, intravenous, subcutaneous, and 
suppository morphine (10 mg). To this end, we used a 
simple randomized list with numerical sequential unique 
identifiers.
The patients undergoing hysterectomy with a body 
weight of 50 to 80 kg and a willingness to participate 
in the study were included. The exclusion criteria were 
addiction, allergies to morphine and similar compounds, 
hepatic and renal failure, pulmonary dysfunction, use of 
monoamine oxidase inhibitors (MAOIs), and a history of 
anesthesia for any reason.  
The sample size was calculated to be 28 for each group 
according to a similar study (15) using STATA software, 
considering the type 1 error=0.05, Power=0.8, Delta=1.30, 
standard deviation=1, M1=5.8, and M2=4.5. Patients 
were selected by simple sampling method and then 
were randomly allocated to three groups using Random 
Allocation software. 
Blinding is a measure in randomized controlled trials 
to reduce detection and performance bias. In the current 
study, patients, interventional physicians, and evaluators 
did not know the status of the groups.
Then, the patients were randomly assigned to three 
groups (A, B, and C groups) of 30 each. The patients were 
given adequate explanations regarding the VAS before 
entering the operating room. After entering the operating 
room, patients were monitored for blood pressure, heart 
rate, and pulse oximetry. Patients received fentanyl (3 µg/
kg), thiopental sodium (5 mg/kg), and atracurium (0.5 mg/
kg) and underwent general anesthesia. Then, the patients 
were intubated and underwent surgery. After surgery and 
transfer to the recovery room, one of the administration 
methods of morphine was used to control pain in each 
group. Group A received intravenous morphine (10 mg), 
group B received subcutaneous morphine (10 mg), and 
group C received suppository morphine (10 mg) (16). 
Morphine was given by the nurse at 0 hour (immediately 
after transfer to recovery). At 4, 8, 12, and 16 hours after 
surgery, morphine was re-administered if the patient had 
pain. Pain intensity was assessed at 0, 4, 8, 12, and 16 
hours after surgery using VAS. For patients whose pain 
was not relieved, pethidine was used and pain intensity was 
recorded in the checklist. If complications occurred, the 
necessary measures would be taken. Patients’ information 
including pain, nausea, vomiting, itching, bradypnea, and 
apnea was collected by checklist. Data were analyzed by 
SPSS version 16.0 using descriptive statistics (frequency, 
percentage, mean, and SD), repeated measures ANOVA, 
ANOVA, and chi-squared test. In repeated measures 
ANOVA, we included groups, time intervals, and 
interaction between them and reported interaction as an 
important subject. P<0.05 was considered the significance 
level.
Results
In this study, there was no difference among groups in 
terms of demographic variables. The flowchart of the 
randomized clinical trial is shown in Figure 1.
Mean and standard deviation of VAS at different 
intervals after surgery in each group are reported in Table 
1 and illustrated in Figure 2. The lowest pain severity at 
0, 4, 8, 12, and 16 hours was observed in the intravenous 
morphine group (Table 1). 
Based on the findings (Table 1), mean pain severity at 
0 hour postoperatively (P=0.004), 4 hours postoperatively 
(P=0.009), 8 hours postoperatively (P=0.009) and 
12 hours postoperatively (P=0.001) was significantly 
different among the three groups (suppository morphine, 
subcutaneous morphine, and intravenous morphine), 
indicating that the mean pain severity at 0, 4, 8 and 12 
hours postoperatively was significantly higher in the 
suppository morphine group than in the other two groups. 
There was no significant difference in pain severity at 16 
hours postoperatively among the three groups (P=0.446).





Suppository morphine Intravenous morphine Subcutaneous morphine
0 9.06±1.08 7.43±2.14 7.50±2.75 0.004
4 7.10±1.88 5.36±1.88 6.56±2.69 0.009
8 6.30±1.53 4.53±1.88 5.80±2.07 0.001
12 4.36±1.58 3.23±1.63 2.83±1.51 0.001
16 1.70±1.11 1.33±1.12 1.50±1.12 0.446
Pvaluea <0.001 <0.001 <0.001
a Repeated measures ANOVA.
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According to the results of repeated measures ANOVA, 
there was a statistically significant difference in pain 
severity at the five intervals (0, 4, 8, 12, and, 16 hours 
postoperatively) among the three groups (suppository 
morphine, subcutaneous morphine, and intravenous 
morphine) (P<0.001) (Table 1). The results of this test 
also showed that there was a significant difference in pain 
severity changes among the three groups (suppository 
morphine, subcutaneous morphine, and intravenous 
morphine) (P<0.001), indicating that the changes were 
significantly higher in the suppository morphine group 
than in the intravenous morphine group (P<0.001) and 
the subcutaneous morphine group (P=0.009) (Table 2).
The frequency of nausea and vomiting was higher in 
the morphine suppository group than in the intravenous 
morphine and subcutaneous morphine groups but there 
was no significant difference between the studied groups 
(P>0.05). None of the patients had itching, apnea, or 
tachycardia. 
The average dose of morphine administered in the 
morphine suppository group (3.3) was higher than that 
in the subcutaneous (2.9) and intravenous morphine (2.7) 
groups. 
Ten patients in the suppository morphine group, 8 
patients in the subcutaneous morphine, and 2 patients in 
the intravenous morphine group received a single dose of 
pethidine (Table 3).
Discussion 
The aim of this study was to compare the efficiency of 
intravenous, subcutaneous, and suppository morphine in 
reducing post-hysterectomy pain. The mean postoperative 
pain score was significantly lower in the subcutaneous 
and intravenous morphine groups than in the suppository 
morphine group; however, the mean postoperative pain 
score in subcutaneous and intravenous morphine groups 
was not significantly different. In addition, the average 
number of doses of morphine was higher in the morphine 
suppository group than in the intravenous and subcutaneous 
morphine groups. Ten patients in the suppository 
morphine group, 8 patients in the subcutaneous morphine 
group, and 2 patients in the intravenous morphine group 
received pethidine. The review of literature shows that no 
study has yet been conducted to compare the efficacy of 
the three administration methods. However, we discussed 
similar studies in this section. In line with the results of 
this study, a study reported that postoperative pain was 
lower in the suppository acetaminophen group than in 
the intravenous acetaminophen group in children and 
request for additional analgesic medication was less in the 
Figure 1. Flowchart of participant enrollment.
Figure 2. Pain intensity at different intervals in the studied groups 
based on the visual analogue scale. 
Mean and standard deviation of VAS at different intervals after surgery in each group are 
reported in Table 1 and illustrated in Figure 2. The lowest pain severity at 0, 4, 8, 12, and 16 
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suppository group than in the intravenous group (17). 
Khalili et al compared the effects of intravenous 
morphine and suppository morphine. Based on the results, 
the mean pain intensity score at 22 hours after surgery 
was not significantly different between the two groups. 
Therefore, injected and suppository morphine acted 
similarly in reducing postoperative pain. In addition, there 
was no significant difference in the level of drowsiness at 
any of the studied intervals between the two groups (18). 
Injected morphine was administered by patient controlled 
analgesia (PCA) and morphine was administered at 
different concentrations. The differences between the 
results of this study and those obtained by Khalil et al 
are due to the administration route and frequency of 
administration of morphine.
Giordano et al conducted a study on the comparison 
of postoperative analgesic effects of intravenous, 
intramuscular, subcutaneous, and oral transmucosal 
buprenorphine in cats. Their results showed that 
intravenous and intramuscular prescription of 
buprenorphine provided better postoperative pain relief 
than subcutaneous and oral transmucosal administration 
of the drug (19). Another study reported that continuous 
epidural morphine did not produce the expected effect 
in the patients undergoing  posterior lumbar interbody 
fusion and continuous subcutaneous morphine  led to 
some analgesic effects with fewer complications (20). In a 
study conducted by Barnhart et al, intravenous morphine 
at 0.5 mg/kg and suppository morphine at 5 mg/kg 
produced similar analgesic effects and Than intravenous 
morphine (21). However, morphine dose was lower in the 
suppository morphine group in the present study than in 
a study conducted by Barnhart et al (21), to which the 
lower efficacy of suppository morphine in our study could 
be attributed.
Overall, the analgesic effects of opioids occur through 
the activation of opioid receptors in the central nervous 
system. Opioid agonists produce analgesia by binding 
to specific receptors coupled to G protein and cause 
cellular hyperpolarization. The majority of clinically 
relevant opioid analgesics bind to MOP receptors in both 
the central and peripheral nervous system in an agonist 
manner to elicit analgesia (22). However, in the present 
study, the administration of suppository morphine had 
less analgesic effects than intravenous and subcutaneous 
morphine, but its administration can be varied depending 
on patient’s preference and pain intensity.
Conclusion
The mean postoperative pain score was lower in the 
subcutaneous and intravenous morphine groups than in the 
morphine suppository group. In addition, the frequency 
of nausea and vomiting was higher in the morphine 
suppository group than in the other groups. Considering 
Table 2. Comparison of postoperative pain intensity among the studied groups
Groups
Mean difference (I-J) Standard error P value
(I) Group (J) Group
Suppository morphine
Intravenous morphine 1.32 0.286 <0.001a
Subcutaneous morphine 0.87 0.286 0.009b
Intravenous morphine
Suppository morphine -1.32 0.286 <0.001a
Subcutaneous morphine -0.45 0.286 0.351
Subcutaneous morphine
Suppository morphine -0.87 0.286 0.009b
Intravenous morphine 0.45 0.286 0.351
a P<0.001 and b P<0.01 










Never 17 21 18
0.057
Once 3 3 8
Twice 6 2 2
Three times 4 4 0
Five times 0 0 2
Nausea
Never 15 15 14
0.84Once 15 13 2
Twice 14 14 2
Single-dose administration 
of pethidine 
10 2 8 -
aANOVA.
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the convenience of subcutaneous administration of 
morphine and its fewer complications, this method is 
suggested to relieve post-hysterectomy pain.
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